MXCT
MaxCyte, Inc. · Healthcare
EVP, Global Sales, Marketing Thomas M. Ross sold $148K of MaxCyte, Inc.
Sold$148,051
$5.08Price
29,133Shares
−100%Stake
What MXCT did after the filing
- The stock from Thu, Jan 5 close, $5.09
- −4.7%
- S&P 500, same days
- +7.3%
Measured over 30 trading days, to the Feb 17 close.
Traded Tue, Jan 3. Filed Thu, Jan 5, 12:31 PM ET, during the session. Returns use the Jan 5 close and the Feb 17 close. Not investment advice.